Physiologically structured cell population dynamic models with applications to combined drug delivery optimisation in oncology
DOI10.1051/MMNP/201611604zbMATH Open1390.35368OpenAlexW2185455490MaRDI QIDQ4607535FDOQ4607535
Authors: J. Clairambault, Olivier Fercoq 
Publication date: 14 March 2018
Published in: Mathematical Modelling of Natural Phenomena (Search for Journal in Brave)
Full work available at URL: https://hal.inria.fr/hal-01413791/file/JO4MMNPnov2016.pdf
Recommendations
- Optimisation of time-scheduled regimen for anti-cancer drug infusion
- Modelling Physiological and Pharmacological Control on Cell Proliferation to Optimise Cancer Treatments
- Evolution of cancer cell populations under cytotoxic therapy and treatment optimisation: insight from a phenotype-structured model
- The influence of PK/PD on the structure of optimal controls in cancer chemotherapy models
- Synchronisation and control of proliferation in cycling cell population models with age structure
cell population dynamicsage-structured modelscell division cycledrug delivery optimisationpharmacological models
Medical applications (general) (92C50) PDEs in connection with biology, chemistry and other natural sciences (35Q92) Existence theories for optimal control problems involving partial differential equations (49J20)
Cites Work
- Title not available (Why is that?)
- Optimization. Algorithms and consistent approximations
- Title not available (Why is that?)
- Transport equations in biology.
- Geometric optimal control. Theory, methods and examples
- Title not available (Why is that?)
- Title not available (Why is that?)
- Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies
- Age-structured cell population model to study the influence of growth factors on cell cycle dynamics
- Synchronisation and control of proliferation in cycling cell population models with age structure
- The contribution of age structure to cell population responses to targeted therapeutics
- Designing proliferating cell population models with functional targets for control by anti-cancer drugs
- On Minimizing the Special Radius of a Nonsymmetric Matrix Function: Optimality Conditions and Duality Theory
- Modeling the effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors
- Optimal control for mathematical models of cancer therapies. An application of geometric methods
- A spatial physiological model for p53 intracellular dynamics
- Optimisation of cancer drug treatments using cell population dynamics
- Modelling Physiological and Pharmacological Control on Cell Proliferation to Optimise Cancer Treatments
- Title not available (Why is that?)
- An inequality for the Perron and Floquet eigenvalues of monotone differential systems and age structured equations
- Comparison of Perron and Floquet Eigenvalues in Age Structured Cell Division Cycle Models
- The control of linear time-periodic systems using Floquet–Lyapunov theory
- Circadian rhythm and tumour growth
- Circadian rhythm and cell population growth
- Asymptotic analysis and optimal control of an integro-differential system modelling healthy and cancer cells exposed to chemotherapy
- Perron vector optimization applied to search engines
- Optimisation of time-scheduled regimen for anti-cancer drug infusion
Cited In (6)
- Optimisation of time-scheduled regimen for anti-cancer drug infusion
- Designing proliferating cell population models with functional targets for control by anti-cancer drugs
- Mathematics of pharmacokinetics and pharmacodynamics: diversity of topics, models and methods
- Modelling Physiological and Pharmacological Control on Cell Proliferation to Optimise Cancer Treatments
- A novel mathematical model of heterogeneous cell proliferation
- Optimization of additive chemotherapy combinations for an in vitro cell cycle model with constant drug exposures
Uses Software
This page was built for publication: Physiologically structured cell population dynamic models with applications to combined drug delivery optimisation in oncology
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4607535)
